TIL FY 2024 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$62M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$74M

Net Income

-$74M

EPS (Diluted)

$-11.39

Cash Flow

Operating Cash Flow

-$56M

Free Cash Flow

-$66M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$264M

Total Liabilities

$94M

Stockholders' Equity

$169M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$74M	-$159M	+53.8%
Net Income	-$74M	-$156M	+52.5%